Introduction {#s1}
============

Phthalates are synthetic chemicals used primarily as plasticizers and chemical additives for various applications. Phthalates are released continuously from such products and are ubiquitous in the environment owing to their chemical properties (i.e., no chemical bonds formed between phthalates and plastics or additives). Consequently, human exposure to phthalates is widespread and common, particularly since phthalates can be absorbed through the skin, inhaled, ingested, or directly administered [@pone.0102788-Talsness1], [@pone.0102788-KasperSonnenberg1].

After exposure, low-molecular-weight (LMW) phthalates are rapidly metabolized into their respective monoester and hydroxy-diester metabolites, and high-molecular-weight (HMW) phthalates are metabolized into monoesters and hydroxy-, oxy-, or carboxy-diester metabolites, which are then excreted via urine [@pone.0102788-KasperSonnenberg1]. Recently, biomonitoring studies have demonstrated relatively high urinary levels of phthalate metabolites in the general population of Western countries [@pone.0102788-KasperSonnenberg1]--[@pone.0102788-Silva1]. Furthermore, concentrations in children, who are more sensitive to exogenous insults, were found to be even higher [@pone.0102788-Talsness1], [@pone.0102788-KasperSonnenberg1], [@pone.0102788-Lin1].

This exposure is of great concern, as phthalates have been suspected to have anti-androgenic and estrogenic effects, which may alter the reproductive development of children [@pone.0102788-Moore1], [@pone.0102788-Harris1]. Indeed, toxicological evidence suggests that some phthalates, including butyl benzyl phthalate (BBzP), di-n-butyl phthalate (DnBP), and di-(2-ethylhexyl) phthalate (DEHP), may alter or mimic estradiol (E2) *in vivo* and *in vitro* [@pone.0102788-Harris1]. Animal studies indicate that gestational phthalate exposure is associated with adverse health outcomes, including disruption of endocrine and reproductive function and development [@pone.0102788-Talsness1]. Furthermore, it was suggested that most reproductive effects of phthalates are not exerted by phthalates *per se*, but rather their metabolites [@pone.0102788-GrayT1]. Recently, a study by Huang et al. [@pone.0102788-Huang1] demonstrated that subjects with a glutathione S-transferase M1 null mutant genotype had not only higher urinary levels of total urinary mono-ethylhexyl phthalate (MEHP), a metabolite of DEHP, but also a significantly higher risk for estrogen-dependent diseases [@pone.0102788-Huang1]. Additionally, studies on newborns have demonstrated associations between prenatal and early postnatal phthalate exposure with shorter anogenital distance, lower serum testosterone levels, and alterations in birth outcomes [@pone.0102788-Main1]--[@pone.0102788-Wolff1]. However, evidence regarding the effects of phthalates on human reproduction, particularly the effects of *in utero* exposure on the reproductive development of pre-pubertal children, is still very limited [@pone.0102788-Jurewicz1].

In the present study, we aimed to examine the association between *in utero* and environmental exposure to phthalate metabolites and the reproductive development of pre-pubertal (i.e., age 8 years) children in Taiwan. The correlations between *in utero* exposure levels and birth outcomes, reproductive hormone levels, and female sexual characteristics were analyzed.

Methods {#s2}
=======

Participants {#s2a}
------------

The present study was a prospective follow-up study of 130 children and their mothers, who were recruited, and were followed from November 2001 to August 2009. This study of the general population in central Taiwan served as pilot for a nation-wide Taiwan Maternal and Infant Cohort Study (TMICS). All children were eight years old at the time of follow-up. Subject recruitment was previously described. This study was approved by the ethics review committee of the National Health Research Institutes in Taiwan, and parental written informed consent was obtained for each participant.

Data and specimen collection {#s2b}
----------------------------

Participants' characteristics at birth and age eight years were determined from records. Data on birth outcomes included sex, gestational age, birth length, birth weight, head circumference, and breast circumference. At age eight years, height, weight, body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were recorded.

At follow-up, bone age (BA) was determined by examining left hand radiographs using the method of Greulich and Pyle [@pone.0102788-Tanner1], and the BA/chronological age (CA) ratio was calculated. Additionally, eight-hour fasting blood samples were obtained from each participant, immediately centrifuged, and the serum was separated and frozen at −70°C for further analysis.

Reproductive hormone measurements {#s2c}
---------------------------------

Serum total testosterone (TT) and progesterone levels were measured using a solid-phase, competitive chemiluminescent enzyme immunoassay (Immulite 2000 Systems Analyzers, Siemens Medical Solutions Diagnostics, Deerfield, Illinois). The sensitivity for TT was 1.5 ng/mL, and for progesterone was 0.1 ng/mL (0.3 nmol/L). Free testosterone levels were determined by a Coat-A-Count Free Testosterone ^125^I radioimmunoassay kit purchased from Diagnostic Products Corp. (Los Angeles, California), which had a sensitivity of 0.15 pg/mL. Serum estradiol (E2) levels were measured using a radioimmunoassay kit (Diagnostic Systems Laboratories, Santa Monica, California), and the sensitivity of this assay was 0.22 ng/dL. Serum follicle-stimulating (FSH) levels were measured via enzyme immunoassays (FSH: Abbott Laboratories, Rome, Italy; LH: Dade Behring, Milan, Italy). The sensitivity of FSH assays was 0.2 mIU/mL.

Evaluation of reproductive development {#s2d}
--------------------------------------

All children underwent detailed examinations for reproductive development, which was scored by the same investigator referring to Tanner staging criteria based on development of genital, breast and pubic hair [@pone.0102788-Marshall1], [@pone.0102788-Marshall2].

Phthalate metabolite measurements {#s2e}
---------------------------------

Urinary phthalate metabolite levels were determined, as previously described [@pone.0102788-Lin1]. Briefly, maternal urine was collected during the third trimester of pregnancy (28--36 weeks) and urine samples of children were obtained at age eight years. Urine samples were collected with a glass beaker. The samples were subsequently transferred into amber glass bottles and stored at −20°C for further analyses. Urinary concentrations of phthalate metabolites (i.e., mono-2-ethylhexyl phthalate \[MEHP\], mono-(2-ethyl-5-hydroxyhexyl) phthalate \[5OHMEHP\], mono-(2-ethyl-5-oxohexyl) phthalate \[5oxo-MEHP\], mono-n-butyl phthalate \[MnBP\], mono-benzyl phthalate \[MBzP\], monomethyl phthalate \[MMP\], and mono-ethyl phthalate \[MEP\]) were determined with liquid chromatography linked to tandem mass spectrometry (LC-MS/MS) by Dr. Jürgen Angerer's laboratory at the University of Erlangen in Germany, as previously described [@pone.0102788-Koch3], [@pone.0102788-Preuss1]. Metabolite concentrations were expressed as µg/L. Total DEHP levels indicated the sum of MEHP, 5OH-MEHP, and 5oxo-MEHP levels. Variability in urinary output was compensated for by adjusting phthalate metabolite concentrations to urinary creatinine levels. Metabolite levels that were adjusted for creatinine were expressed as micrograms per grams of creatinine (µg/gC). Urinary creatinine levels were measured at the Kaohsiung Medical University Chung-Ho Memorial Hospital using spectrophotometric methods, with picric acid as the reactive and the reader set at 520 nm.

Statistical analysis {#s2f}
--------------------

Birth outcomes, children's characteristics, and sexual characteristics (Tanner scores) of girls were summarized as means and standard deviations (mean ± SD) for continuous variables and n (%) for categorical variables. Sex differences were compared by using a two-sample t-test, if data were normally distributed, or a Mann-Whitney U-test, if data were not normally distributed, for continuous variables, and a Pearson Chi-square test for categorical variables. Maternal and offspring phthalate metabolites with adjustments for creatinine were summarized as geometric means and 95% confidence intervals (CI). Spearman's correlation analyses were performed to determine the relationships between maternal and offspring phthalate metabolite levels. Simple linear and binary logistic regression analyses were also performed to determine the factors associated with phthalate metabolite levels. Moreover, prior to conducting correlation and association analyses, birth outcomes, including birth weight, birth length, and head circumference, were adjusted for gestational age and expressed as a Z-score for analysis. All statistical assessments were two-tailed and considered statistically significant if *P* \<0.00625 (0.05/8). Statistical analyses were performed using SPSS 15.0 statistics software (SPSS Inc, Chicago, Illinois).

Results {#s3}
=======

Participants' characteristics {#s3a}
-----------------------------

A total of 130 children (61 boys and 69 girls) aged eight years, were enrolled into this prospective follow-up study. The birth outcomes, specifically birth weights, birth lengths, and head circumferences of newborns stratified by gestational age are shown in [Table S1](#pone.0102788.s001){ref-type="supplementary-material"}. Of the 130 children included in this study, only three had a gestational age of \<37 weeks ([Table S1](#pone.0102788.s001){ref-type="supplementary-material"}). [Table 1](#pone-0102788-t001){ref-type="table"} presents the birth outcomes, and children's physical characteristics and reproductive hormone levels at eight years of age of the entire cohort, as well as stratified by sex. At age eight years, girls had a higher BA and BA/CA ratio than boys (*P*\<0.001). Prior to conducting correlation and regression analyses, the Z-scores of all birth outcomes for gestational age were calculated ([Table S2](#pone.0102788.s002){ref-type="supplementary-material"}). For the sexual characteristics of eight-year-old children, we did not observe any boy who had enter the Tanner stage 2. Of the 69 girls, 42 (60.9%) were classified at Tanner stage 1, 22 (31.9%) at Tanner stage 2 and 5 (7.3%) at Tanner stage 3 ([Table 1](#pone-0102788-t001){ref-type="table"}).

10.1371/journal.pone.0102788.t001

###### Birth outcomes, and children's physical characteristics, reproductive hormone levels and sexual characteristics at eight years of age.

![](pone.0102788.t001){#pone-0102788-t001-1}

  Variables                                                                n         Total              Boys              Girls                        *P*-value
  ---------------------------------------------------------------------- ----- ------------------ ----------------- ------------------ ------------------------------------------
  ***Birth outcomes***                                                                                                                 
  Gestational age, weeks                                                  86      38.71 ± 2.16      38.86 ± 1.27       38.55 ± 2.82                      0.746
  Birth length, cm                                                        121     51.43 ± 2.29      51.82 ± 1.97       51.11 ± 2.50                      0.172
  Birth weight, g                                                         121   3136.84 ± 405.15   3217.09 ±368.52   3069.97 ± 424.52                    0.046
  Head circumference, cm                                                  121     33.58 ± 1.31      33.65 ± 1.20       33.52 ± 1.41                      0.535
  Breast circumference, cm                                                121     32.92 ± 1.59      32.95 ± 1.50       32.89 ± 1.68                      0.877
  Preterm                                                                 86       14 (16.3%)         7(15.9%)          7 (16.7%)                          1
  ***Children at 8 years of age***                                                                                                     
  Height, cm                                                              130    130.69 ± 5.41      130.57 ± 5.97      130.8 ± 4.91                      0.968
  Weight, kg                                                              130     29.18 ± 7.1       29.36 ± 6.07       29.02 ± 7.93                      0.808
  Body mass index, kg/m^2^                                                130     16.94 ± 3.14      17.11 ± 2.64       16.79 ± 3.53                      0.155
  Systolic blood pressure, mmHg                                           130     98.7 ± 8.87       99.25 ± 7.58       98.22 ± 9.9                       0.377
  Diastolic blood pressure, mmHg                                          130     63.16 ± 7.9       62.43 ± 6.49       63.8 ± 8.97                       0.314
  Bone age                                                                130     7.36 ± 2.08        5.93 ± 1.39       8.62 ± 1.76      \<0.001[\*](#nt103){ref-type="table-fn"}
  Bone age/chronological age ratio                                        130     0.92 ± 0.26        0.74 ± 0.16       1.08 ± 0.22      \<0.001[\*](#nt103){ref-type="table-fn"}
  Estradiol, ng/dL[a](#nt104){ref-type="table-fn"}                        126     2.32 ± 1.53        2.12 ± 1.51        2.5 ± 1.54                       0.151
  Follicle-stimulating hormone, mIU/mL[a](#nt104){ref-type="table-fn"}    125     5.37 ± 11.38      4.42 ± 10.05       6.24 ± 12.5                       0.681
  Free testosterone, pg/mL[a](#nt104){ref-type="table-fn"}                130     0.01 ± 0.07           0 ± 0          0.02 ± 0.09                       0.328
  Progesterone, ng/mL[a](#nt104){ref-type="table-fn"}                     130     0.15 ± 0.17        0.14 ± 0.19       0.15 ± 0.15                       0.108
  Total testosterone, ng/mL[a](#nt104){ref-type="table-fn"}               123     0.26 ± 0.09        0.25 ± 0.08        0.26 ± 0.1                       0.887
  Tanner stage (Girls) Stage 1                                            69                                            42 (60.9%)     
         Stage 2                                                          69                                            22 (31.9%)     
         Stage 3                                                          69                                             5 (7.3%)      

Data are presented as mean±SD for continuous variables and n (%) for categorical ones.

Sex differences were compared by using a two-sample t-test, if data were normally distributed, or a Mann-Whitney U-test, if data were not normally distributed, for continuous variables, and a Pearson Chi-square test for categorical variables.

\* *P*\<0.00625 (0.05/8) indicates a significant difference.

Reference values: Estradiol, 0.5--1.1 ng/dL for male, 0.5--2.0 ng/dL for female; Follicle-stimulating hormone, 0.26--3.0 mIU/mL for male, 1.0--4.2 mIU/mL for female; Free testosterone, 0.4--0.9 pg/mL for male and female; Progesterone, \<0.1--0.33 ng/mL for male and female; Total testosterone, \<0.03--0.1 ng/mL for male, \<0.03--0.1 ng/mL for female.

(Table 710--6. In Behrman, Kliegman, Jenson, eds. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 17^th^ edition, 2003:2406--2411).

Phthalate metabolite levels of mothers and children {#s3b}
---------------------------------------------------

[Table 2](#pone-0102788-t002){ref-type="table"} presents the urinary phthalate metabolite levels (i.e., exposure levels) of mothers and their children at eight years of age. Boys had significantly higher urine creatinine levels than girls (48.7 vs. 27.71 mg/dL; *P*\<0.001). After exposure levels were adjusted for creatinine, no significant differences were found between boys and girls in either *in utero* exposure levels and urinary phthalate metabolite levels at eight years of age.

10.1371/journal.pone.0102788.t002

###### Phthalate metabolite levels of mothers and eight-year-old children after adjusting for creatinine.

![](pone.0102788.t002){#pone-0102788-t002-2}

                             Maternal phthalate metabolites levels   Phthalate metabolites levels of 8-year-old children                                                                                 
  ------------------------- --------------------------------------- ----------------------------------------------------- ---------------- ------- ----------------- ----------------- ----------------- ------------------------------------------
  Urine creatinine, mg/dL                    59.79                                          65.1                               55.45        0.339        36.1              48.7              27.71        \<0.001[\*](#nt107){ref-type="table-fn"}
                                        (52.74, 67.78)                                 (54.84, 77.28)                      (46.15, 66.62)           (31.31, 41.63)    (39.69, 59.77)    (23.14, 33.18)   
  MEHP                                       17.15                                          16.79                              17.47        0.915        8.36              9.56              7.43                          0.049
                                        (14.56, 20.19)                                 (13.09, 21.54)                      (14.0, 21.79)             (6.74, 10.37)     (7.13, 12.81)     (5.41, 10.21)   
  5OH-MEHP                                    7.6                                           9.26                                6.38        0.261        43.03             45.69             40.81                         0.346
                                         (5.49, 10.53)                                  (5.7, 15.04)                        (4.08, 9.98)            (36.98, 50.08)    (35.96, 58.04)     (33.52, 49.7)   
  5oxo-MEHP                                  13.29                                          15.06                               11.9        0.579        36.6              39.68             34.07                         0.165
                                        (10.05, 17.58)                                  (9.66, 23.5)                       (8.31, 17.04)            (31.46, 42.58)    (31.47, 50.02)    (27.83, 41.72)   
  Total DEHP                                 50.71                                          55.03                              47.18        0.595        91.7              97.28             87.04                         0.215
                                        (42.28, 60.83)                                  (40.75, 74.3)                      (37.76, 58.95)           (78.38, 107.28)   (76.9, 123.05)    (70.19, 107.93)  
  MnBP                                        66                                            64.11                              67.71        0.937        93.95             84.55            103.13                         0.261
                                        (55.65, 78.27)                                 (51.04, 80.53)                      (52.44, 87.44)           (82.43, 107.08)   (70.22, 101.79)   (85.67, 124.15)  
  MBzP                                       15.72                                          14.18                              17.23        0.236        10.45             11.38             9.69                          0.307
                                        (13.79, 17.93)                                 (11.61, 17.31)                      (14.46, 20.52)            (8.61, 12.69)     (8.37, 15.47)     (7.54, 12.45)   
  MMP                                        53.51                                          54.2                                52.9        0.816        7.14              6.41              7.86                          0.235
                                         (44.39, 64.5)                                 (40.73, 72.14)                      (41.11, 68.06)            (5.93, 8.59)      (4.86, 8.44)      (6.09, 10.13)   
  MEP                                        61.15                                          57.41                              64.67        0.52         15.96             13.33             18.72                         0.084
                                        (52.26, 71.56)                                 (45.46, 72.51)                      (52.06, 80.34)           (13.26, 19.21)    (10.35, 17.17)    (14.32, 24.47)   

Data are presented as geometric means and 95% CI, and metabolite concentrations were expressed relative to creatinine levels (mg/g). Sex differences were compared by using the Mann-Whitney U-test.

\* *P*\<0.00625 (0.05/8) indicates a significant difference.

*Abbreviations:* MEHP, mono-2-ethylhexyl phthalate; 5OH-MEHP, mono-(2-ethyl-5-hydroxyhexyl) phthalate; 5oxo-MEHP, mono-(2-ethyl-5-oxohexyl) phthalate; DEHP, di-(2-ethylhexyl) phthalate; MnBP, mono-n-butyl phthalate;MBzP, mono-benzyl phthalate; MMP, monomethyl phthalate; MEP, mono-ethyl phthalate.

Maternal urinary phthalate metabolite levels and birth outcomes {#s3c}
---------------------------------------------------------------

The correlations between birth outcomes and maternal urinary phthalate metabolite levels are presented in [Table 3](#pone-0102788-t003){ref-type="table"} and [Table 4](#pone-0102788-t004){ref-type="table"}. No significant correlations were found between maternal urinary levels of phthalate metabolites and birth outcomes ([Tables 3](#pone-0102788-t003){ref-type="table"} and [4](#pone-0102788-t004){ref-type="table"}). Of the phthalate metabolites tested in this study, only *in utero* exposure to MMP had a negative correlation with birth weight in boys (r = −0.423, *P*  = 0.006) ([Table S3](#pone.0102788.s003){ref-type="supplementary-material"}). In addition, urinary phthalate metabolite levels of children age eight years did not correlate with maternal urinary levels of phthalate metabolites ([Tables 3](#pone-0102788-t003){ref-type="table"}, [4](#pone-0102788-t004){ref-type="table"}, [Table S3](#pone.0102788.s003){ref-type="supplementary-material"}). In addition, maternal urinary levels of phthalate metabolites did not correlate with the physical characteristics and reproductive development of children aged eight years ([Table S4](#pone.0102788.s004){ref-type="supplementary-material"}).

10.1371/journal.pone.0102788.t003

###### Effects of material urinary levels of phthalate metabolites on the birth outcome and the phthalate metabolites levels of eight-year-old children.

![](pone.0102788.t003){#pone-0102788-t003-3}

                                                                                      MEHP           5OH-MEHP   5oxo-MEHP        Total DEHP                                                                                                                               
  ----------------- -------------------------------------------------------- ---------------------- ---------- ----------- ---------------------- ------- ------- ---------------------- ---------------------------------------- -------- ---------------------- ------- --------
  Total (n = 130)                                                                                                                                                                                                                                                         
                                      ***Birth outcomes***                                                                                                                                                                                                                
                                     Gestational age, weeks                      .0040 (.0030)        0.193       0.02         .0051 (.0039)       0.201   0.019      .0027 (.0019)                       0.143                    0.025       .0013 (.0009)       0.157   0.024
                        Birth weight, g[a](#nt110){ref-type="table-fn"}           .001 (.001)         0.355       0.011         .002 (.002)        0.169   0.023       .001 (.001)                        0.209                    0.019        .001 (.0004)       0.223   0.018
                        Birth length, cm[a](#nt110){ref-type="table-fn"}          .002 (.001)         0.093       0.034         .002 (.002)        0.141   0.027       .001 (.001)                        0.162                    0.024        .001 (.0004)       0.123   0.029
                     Head circumference, cm[a](#nt110){ref-type="table-fn"}       .002 (.001)         0.188       0.021         .003 (.002)        0.106   0.032       .002 (.001)                        0.062                    0.042        .001 (.0004)       0.09    0.035
                                         Sex (M vs. F)                        1.027 (0.985--1.071)    0.215       0.028     1.007 (0.998--1.016)   0.133   0.033   1.006 (0.999--1.014)                   0.114                    0.049    1.002 (0.999--1.005)   0.199   0.029
                         Phthalate metabolite levels at 8 years of age          --.0487 (.1572)       0.757       0.001        .0314 (.3778)       0.934     0       --.0364 (.1572)                      0.817                      0        --.0417 (.2087)      0.842     0
  Boys (n = 61)                                                                                                                                                                                                                                                           
                                      ***Birth outcomes***                                                                                                                                                                                                                
                                     Gestational age, weeks                      .0030 (.0018)        0.105       0.061        .0054 (.0023)       0.025   0.114      .0025 (.0011)                       0.026                    0.112       .0011 (.0005)       0.036    0.1
                        Birth weight, g[a](#nt110){ref-type="table-fn"}           .001 (.001)         0.421       0.017         .002 (.002)        0.314   0.026       .001 (.001)                         0.38                     0.02       .0004 (.0004)       0.366   0.021
                        Birth length, cm[a](#nt110){ref-type="table-fn"}          .002 (.001)         0.104       0.066         .003 (.002)        0.099   0.068       .001 (.001)                        0.184                    0.045        .001 (.0004)       0.128   0.058
                     Head circumference, cm[a](#nt110){ref-type="table-fn"}       .002 (.001)         0.148       0.053         .004 (.002)        0.017   0.137       .002 (.001)        0.020[\*](#nt111){ref-type="table-fn"}   0.132        .001 (.0004)       0.034    0.11
                         Phthalate metabolite levels at 8 years of age          --.0499 (.1362)       0.715       0.002       --.0366 (.5125)      0.943     0       --.0855 (.2011)                      0.672                    0.003       .0917 (.2706)       0.736   0.002
  Girls (n = 69)                                                                                                                                                                                                                                                          
                                      ***Birth outcomes***                                                                                                                                                                                                                
                                     Gestational age, weeks                      .0224 (.0188)        0.241       0.034       --.0022 (.0184)      0.904     0        .0074 (.0145)                       0.611                    0.007       .0042 (.0069)       0.539   0.009
                        Birth weight, g[a](#nt110){ref-type="table-fn"}          --.003 (.006)        0.664       0.005         .001 (.006)        0.878   0.001       .0004 (.005)                       0.926                    \<.001     --.0001 (.0022)      0.956   \<.001
                        Birth length, cm[a](#nt110){ref-type="table-fn"}          .001 (.007)         0.891      \<.001        --.006 (.006)       0.35    0.022      --.003 (.005)                       0.519                     0.01       --.001 (.002)       0.546   0.009
                     Head circumference, cm[a](#nt110){ref-type="table-fn"}      --.002 (.007)        0.803       0.002        --.012 (.007)       0.075   0.077      --.009 (.005)                       0.085                    0.073       --.004 (.002)       0.117    0.06
                         Phthalate metabolite levels at 8 years of age          --.0261 (.4925)       0.958         0          .1969 (.7954)       0.805   0.001      .6792 (.5953)                       0.258                    0.019       .4559 (.6178)       0.463   0.008

Data are presented as β (SE) and R^2^ for linear regression analysis or OR (95%.CI) and Nagelkerke R^2^for binary logistical regression analysis.

Z-scores of birth outcomes, including body weight, body length, and head circumference, for gestational age were calculated prior to conducting correlation analysis.

\* *P*\<0.00625 (0.05/8) indicates a significant correlation.

*Abbreviations:* MEHP, mono-2-ethylhexyl phthalate; 5OH-MEHP, mono-(2-ethyl-5-hydroxyhexyl) phthalate; 5oxo-MEHP, mono-(2-ethyl-5-oxohexyl) phthalate; DEHP, di-(2-ethylhexyl) phthalate.

10.1371/journal.pone.0102788.t004

###### Effects of material urinary levels of phthalate metabolites on the birth outcome and the phthalate metabolites level levels of eight-year-old children.

![](pone.0102788.t004){#pone-0102788-t004-4}

                                                                                      MnBP           MBzP     MMP             MEP                                                                                                   
  ----------------- -------------------------------------------------------- ---------------------- ------- -------- ---------------------- ------- -------- ---------------------- ------- -------- ---------------------- ------- --------
  Total (n = 130)                                                                                                                                                                                                                   
                                      ***Birth outcomes***                                                                                                                                                                          
                                     Gestational age, weeks                      .0011 (.0021)       0.609   0.003       .0122 (.0149)       0.414   0.008      --.0004 (.0022)      0.861     0         .0008 (.0016)       0.607   0.003
                        Birth weight, g[a](#nt114){ref-type="table-fn"}           .001 (.001)        0.367    0.01       --.006 (.007)       0.36     0.01       --.0002 (.001)      0.825   0.001       --.0001 (.001)      0.909   \<.001
                        Birth length, cm[a](#nt114){ref-type="table-fn"}          .001 (.001)        0.544   0.005       --.002 (.006)       0.792   0.001       --.001 (.001)       0.598   0.003       --.0001 (.001)      0.859   \<.001
                     Head circumference, cm[a](#nt114){ref-type="table-fn"}       .0001 (.001)       0.958   \<.001      --.001 (.007)       0.85    \<.001      --.001 (.001)       0.899   \<.001       .0002 (.001)       0.759   0.001
                                         Sex (M vs. F)                        0.999 (0.995--1.002)   0.337    0.01    0.972 (0.945--1.001)   0.056   0.047    1.001 (0.997--1.004)   0.741   0.001    1.000 (0.997--1.003)   0.959     0
                         Phthalate metabolite levels at 8 years of age           .2298 (0.1049)      0.03    0.036       .1419 (0.3182)      0.656   0.002      --.0042 (.0192)      0.828     0         .0209 (.0460)       0.65    0.002
  Boys (n = 61)                                                                                                                                                                                                                     
                                      ***Birth outcomes***                                                                                                                                                                          
                                     Gestational age, weeks                     --.0006 (.0029)      0.841   0.001       .0269 (.0184)       0.151   0.048      --.0006 (.0015)      0.685   0.004      --.0010 (.0011)      0.384   0.018
                        Birth weight, g[a](#nt114){ref-type="table-fn"}           .004 (.002)        0.057    0.09       --.026 (.014)       0.069   0.003       --.001 (.001)       0.265   0.032       --.001 (.001)       0.55    0.009
                        Birth length, cm[a](#nt114){ref-type="table-fn"}          .005 (.002)        0.02     0.13       --.008 (.013)       0.539    0.01       --.001 (.001)       0.291   0.029        .0001 (.001)       0.918   \<.001
                     Head circumference, cm[a](#nt114){ref-type="table-fn"}       .002 (.002)        0.432   0.016       --.008 (.013)       0.527    0.01       --.001 (.001)       0.508   0.011      --.0002 (0.001)      0.759   0.002
                         Phthalate metabolite levels at 8 years of age           .0506 (.1431)       0.725   0.002      1.4022 (1.0567)      0.19    0.029      --.0227 (.0230)      0.328   0.016      --.0345 (.0418)      0.413   0.011
  Girls (n = 69)                                                                                                                                                                                                                    
                                      ***Birth outcomes***                                                                                                                                                                          
                                     Gestational age, weeks                      .0019 (.0031)       0.544   0.009       .0108 (.0226)       0.635   0.006       .0001 (.0058)       0.992     0         .0045 (.0036)       0.211   0.039
                        Birth weight, g[a](#nt114){ref-type="table-fn"}           .001 (.001)        0.444   0.015        .003 (.007)        0.713   0.003        .002 (.002)        0.243   0.034        .001 (.001)        0.594   0.007
                        Birth length, cm[a](#nt114){ref-type="table-fn"}          .0002 (.001)       0.855   0.001        .003 (.008)        0.718   0.003        .001 (.002)        0.74    0.003       --.001 (.001)       0.578   0.008
                     Head circumference, cm[a](#nt114){ref-type="table-fn"}     --.0001 (0.001)      0.952   \<.001       .001 (.008)        0.811   0.001        .001 (.001)        0.540   0.009        .001 (.001)        0.407   0.017
                         Phthalate metabolite levels at 8 years of age           .2997 (.1487)       0.048   0.057      --.0330 (.1827)      0.857     0         .0337 (.0339)       0.324   0.014       .1021 (.0865)       0.242    0.02

Data are presented as β (SE) and R^2^ for linear regression analysis or OR (95%.CI) and Nagelkerke R^2^for binary logistical regression analysis.

Z-scores of birth outcomes, including body weight, body length, and head circumference, for gestational age were calculated prior to conducting correlation analysis.

\* *P*\<0.00625 (0.05/8) indicates a significant correlation.

*Abbreviations:* MnBP, mono-n-butyl phthalate; MBzP, mono-benzyl phthalate; MMP, monomethyl phthalate; MEP, mono-ethyl phthalate.

Phthalate metabolites of eight-year-old children and their development {#s3d}
----------------------------------------------------------------------

The linear correlation between the physical characteristics and reproductive development of children aged eight years and their urinary phthalate metabolite levels are presented in [Table 5](#pone-0102788-t005){ref-type="table"} and [Table 6](#pone-0102788-t006){ref-type="table"}. Urinary MEHP levels correlated significantly with serum progesterone levels (β = 0.0004; SE = 0.0001; *P* = 0.006; R^2^ = 0.060) ([Table 5](#pone-0102788-t005){ref-type="table"}). Additionally, urinary MEHP levels in girls correlated significantly with serum progesterone levels (β = 5.1×10^4^; SE = 1.2×10^4^; *P*\<0.001; R^2^ = 0.225). Additionally, urinary levels of MnBP correlated significantly with serum FSH levels in all eight-year-old children (β = 0.0192; SE = 0.0069; *P* = 0.006; R^2^ = 0.060). In girls, MnBP levels correlated significantly with serum FSH levels (β = 0.026; SE = 0.0086; *P* = 0.004; R^2^ = 0.125). Additionally, MBzP levels in girls correlated significantly with serum FSH (β = 0.1726; SE = 0.0471; *P* = 0.001; R^2^ = 0.175) and progesterone (β = 0.0018; SE = 0.0006; P = 0.002; R^2^ = 0.137) levels ([Table 6](#pone-0102788-t006){ref-type="table"}).

10.1371/journal.pone.0102788.t005

###### Effects of urinary phthalate metabolite levels of eight-year-old children on their physical characteristics and reproductive development.

![](pone.0102788.t005){#pone-0102788-t005-5}

                                                                                    MEHP                                             5OH-MEHP                     5oxo-MEHP            Total DEHP                                                                                                                  
  ----------------- --------------------------------------- ----------------------------------------------------- ---------------------------------------------- ----------- ------------------------------- ------- ------- ------------------------------ ------- ------- ------------------------------ ------- -------
  Total (n = 130)                                                                                                                                                                                                                                                                                                  
                                   Bone age                                     --.002 (.002)                                         0.223                         0.012             --.001 (.001)           0.225   0.011          --.001 (.001)           0.191   0.013         --.0005 (.0004)          0.179   0.014
                       Bone age/chronological age ratio                        --.0002 (.0002)                                         0.23                         0.011            --.0001 (.0001)          0.228   0.011         --.0002 (.0001)          0.197   0.013      --.6×10^−4^(.4×10^−4^)      0.183   0.014
                               Estradiol, ng/dL                                 .0014 (.0011)                                         0.234                         0.011             .0006 (.0005)           0.296   0.009          .0007 (.0007)           0.327   0.008          .0003 (.0003)           0.256   0.01
                     Follicle-stimulating hormone, mIU/mL                       .0144 (.0085)                                         0.091                         0.023            --.0027 (.0040)           0.5    0.004         --.0032 (.0053)          0.543   0.003         --.0003 (.0020)          0.868     0
                           Free testosterone, pg/mL                      --.6×10^--5^ (5.1×10^--5^ )                                  0.907                           0         .3×10^--5^ (2.4×10^--5^)      0.907     0       .5×10^--5^ (3.2×10^--5^)     0.873     0      .1 ×10^--5^ (1.2×10^--5^)     0.929     0
                              Progesterone, ng/mL            **.0004 (.0001)** [\*](#nt118){ref-type="table-fn"}   **0.006** [\*](#nt118){ref-type="table-fn"}    **0.06**           --.0003 (.0006)          0.609   0.002         --.0004 (.0008)          0.617   0.002    --.5×10^--5^ (2.9×10^--5^)    0.851     0
                           Total testosterone, ng/mL                           --.0004 (.0007)                                        0.528                         0.003            --.0005 (.0003)          0.152   0.017         --.0006 (.0004)          0.127   0.019         --.0002 (.0002)          0.162   0.016
  Boys (n = 61)                                                                                                                                                                                                                                                                                                    
                                   Bone age                                     --.001 (.002)                                         0.575                         0.005            .0003 (0.0006)           0.567   0.006         --.0004 (.0008)          0.563   0.006         --.0002 (.0003)          0.566   0.006
                       Bone age/chronological age ratio                  --1.2×10^--4^ (2.2×10^--4^)                                  0.586                         0.005        .4×10^--4^ (.7×10^--4^)      0.562   0.006    --.5×10^--4^ (.9×10^--4^ )    0.566   0.006   --.18 ×10^--4^ (.32×10^--4^)   0.566   0.006
                               Estradiol, ng/dL                                 .0027 (.0020)                                         0.187                         0.03              .0008 (.0006)           0.17    0.032          .0011 (.0008)           0.17    0.032          .0004 (.0003)           0.171   0.032
                     Follicle--stimulating hormone, mIU/mL                     --.0081 (.0138)                                        0.559                         0.006            --.0029 (.0042)          0.493   0.008         --.0039 (.0055)          0.48    0.009         --.0014 (.0020)          0.497   0.008
                           Free testosterone, pg/mL                       --.1×10^--5^ (.4×10^--5^)                                   0.834                         0.001      --.4×10^--6^ (1.3×10^--6)^     0.765   0.002    --.5×10^--6^ (1.7×10^--6^)    0.767   0.002    --.2×10^--6^ (.6×10^--6^)     0.776   0.001
                              Progesterone, ng/mL                        --.4×10^--4^ (2.6×10^--4^)                                   0.875                           0          .3×10^--6^ (79×10^--6^)      0.997     0      .1×10^--5^ (10.5×10^--5^)     0.993     0     --.7×10^--6^ (38.6×10^--6^)    0.985     0
                           Total testosterone, ng/mL                           --.0002 (.0001)                                        0.193                         0.03             --.0005 (.0003)          0.133   0.04          --.0007 (.0005)          0.12    0.043         --.0003 (.0002)          0.135   0.039
  Girls (n = 69)                                                                                                                                                                                                                                                                                                   
                                   Bone age                                     --.003 (.002)                                         0.087                         0.043             --.001 (.001)           0.325   0.014          --.002 (.002)           0.234   0.021          --.001 (.001)           0.129   0.034
                       Bone age/chronological age ratio                  --3.3×10^--4^ (1.9×10^--4^)                                  0.087                         0.043     --1.5×10^--4^ (1.5×10^--4^ )    0.329   0.014   --2.2×10^--4^ (.1.9×10^--4^)   0.239   0.021   --1.1×10^--4^ (.7×10^--4^ )    0.131   0.034
                               Estradiol, ng/dL                                 .0007 (.0014)                                         0.608                         0.004            --.0001 (.0011)          0.951     0           --.0002 (.0013)          0.888     0            .0001 (.0005)           0.918     0
                     Follicle--stimulating hormone, mIU/mL                      .0237 (.0109)                                         0.033                         0.07             --.0015 (.0087)          0.86    0.001         --.0006 (.0108)          0.957     0            .0026 (.0040)           0.516   0.007
                           Free testosterone, pg/mL                      --1.1×10^--5^ (8.4×10^--5^)                                  0.896                           0       --19.1×10^--6^ (64.8×10^--6^)   0.769   0.001   27.1×10^--6^ (80.9×10^--6^)    0.739   0.002    6.5×10^--6^ (30.2×10^--6^)    0.83    0.001
                              Progesterone, ng/mL                       **5.1×10^--4^ (1.2×10^--4^)**              **\<.001** [\*](#nt118){ref-type="table-fn"}   **0.225**   --113.0×10^--6^ (103×10^--6^)   0.275   0.019   --1.3×10^--5^ (12.8×10^--5^)   0.304   0.016   22.6×10^--6^ (.48.2×10^--6^)   0.641   0.003
                           Total testosterone, ng/mL                      .2×10^--5^ (8.7×10^--5^)                                     0.98                           0              --.0003 (.0007)          0.684   0.003         --.0004 (.0008)          0.609   0.004         --.0001 (.0003)          0.71    0.002
                                 Tanner stage                                                                                                                       0.014                                             0.027                                          0.025                                          0.021
                                    Stage 1                                       Reference                                                                                             Reference                                      Reference                                      Reference                    
                                    Stage 2                                 1.000 (0.995, 1.004)                                      0.822                                       1.002 (0.998, 1.005)        0.358               1.002 (0.998, 1.006)       0.375               1.001 (0.999, 1.002)       0.448  
                                    Stage 3                                 0.976 (0.895, 1.064)                                      0.578                                       0.995 (0.970, 1.021)        0.705               0.994 (00964, 1.024)       0.684               0.997 (0.985, 1.009)       0.631  

Data are presented as β (SE) and R^2^ for linear regression analysis or OR (95%.CI) and Nagelkerke R^2^for binary logistical regression analysis.

\* *P*\<0.00625 (0.05/8) indicates a significant correlation.

*Abbreviations:* MEHP, mono-2-ethylhexyl phthalate; 5OH-MEHP, mono-(2-ethyl-5-hydroxyhexyl) phthalate; 5oxo-MEHP, mono-(2-ethyl-5-oxohexyl) phthalate; DEHP, di-(2-ethylhexyl) phthalate.

10.1371/journal.pone.0102788.t006

###### Effects of urinary phthalate metabolite levels of eight-year-old children on their physical characteristics and reproductive development.

![](pone.0102788.t006){#pone-0102788-t006-6}

                                                                         MnBP                                   MBzP                          MMP                  MEP                                                                                                                                                               
  ----------------- --------------------------------------- ------------------------------- --------------------------------------------- ----------- ------------------------------ --------------------------------------------- ----------- ------------------------------- ------- ------- ----------------------------- ------- -------
  Total (n = 130)                                                                                                                                                                                                                                                                                                                    
                                   Bone age                         --.0012 (.0013)                             0.336                        0.007           --.0035 (.0032)                             0.269                        0.01              .0021 (.0088)           0.807     0            .0036 (.0026)          0.169   0.015
                       Bone age/chronological age ratio             --.0001 (.0002)                             0.369                        0.006           --.0004 (.0004)                             0.27                         0.01              .0003 (.0011)           0.781   0.001          .0005 (.0003)          0.146   0.016
                               Estradiol, ng/dL                     --.0004 (.0009)                             0.67                         0.001           --.0018 (.0023)                             0.44                         0.005            --.0085 (.0064)          0.186   0.014         --.0007 (.0019)         0.713   0.001
                     Follicle-stimulating hormone, mIU/mL          **.0192 (.0069)**         **0.006** [\*](#nt121){ref-type="table-fn"}   **0.06**           .0124 (.0174)                              0.478                        0.004             .0135 (.0479)           0.778   0.001         --.0057 (.0144)         0.692   0.001
                           Free testosterone, pg/mL           --2.0×10^--5^ (4.2×10^--5^)                       0.633                        0.002     --2.6×10^--5^ (10.4×10^--5^)                      0.806                          0       --12.9×10^--5^ (28.6×10^--5^)   0.652   0.002   9.73×10^--5^ (8.55×10^--5^)   0.257   0.01
                              Progesterone, ng/mL                    .0002 (.0001)                              0.147                        0.017           .00001 (.00026)                             0.977                          0              --.0007 (.0007)          0.319   0.008         --.0001 (.0002)         0.608   0.002
                           Total testosterone, ng/mL               --.00003 (.00006)                            0.609                        0.002          --.00002 (.00014)                            0.868                          0             --.00045 (.00038)         0.236   0.012         .00014 (.00011)         0.235   0.012
  Boys (n = 61)                                                                                                                                                                                                                                                                                                                      
                                   Bone age                          .0002 (.0017)                              0.883                          0             --.0003 (.0023)                             0.902                          0               .0060 (.0087)           0.498   0.008          .0005 (.0037)          0.902     0
                       Bone age/chronological age ratio              .0001 (.0002)                              0.784                        0.001           --.00003 (.0003)                            0.914                          0               .0008 (.0010)           0.406   0.012          .0001 (.0004)          0.827   0.001
                               Estradiol, ng/dL                    --.0021 (0.0018)                             0.256                        0.022           --.0031 (.0025)                             0.212                        0.027            --.0182 (.0092)          0.053   0.063         --.0019 (.0040)         0.63    0.004
                     Follicle--stimulating hormone, mIU/mL          --.0005 (.0121)                             0.964                          0             --.0117 (.0167)                             0.487                        0.008            --.0324 (.0633)          0.611   0.004         --.0176 (.0264)         0.508   0.008
                           Free testosterone, pg/mL            --.2×10^--5^ (.4×10^--5^)                        0.636                        0.004      --.1×10^--5^ (.5×10^--5^)                        0.885                          0        --.7×10^--5^ (2.0×10^--5^)     0.717   0.002    --.4×10^--5^ (.8×10^--5^)    0.64    0.004
                              Progesterone, ng/mL                   --.0002 (.0002)                             0.495                        0.008           --.0003 (.0003)                             0.379                        0.013            --.0012 (.0012)          0.33    0.016         --.0002 (.0005)         0.642   0.004
                           Total testosterone, ng/mL               --.00007 (.00010)                            0.48                         0.009           .00002 (.00014)                             0.905                          0             --.00057 (.00053)         0.282   0.021         .00013 (.00022)         0.57    0.006
  Girls (n = 69)                                                                                                                                                                                                                                                                                                                     
                                   Bone age                         --.0034 (.0012)                             0.007                        0.105           --.0072 (.0072)                             0.321                        0.015            --.0053 (.0010)          0.597   0.004          .0017 (.0026)          0.504   0.007
                       Bone age/chronological age ratio             --.0004 (.0002)                             0.007                        0.103           --.0009 (.0009)                             0.336                        0.014            --.0007 (.0012)          0.584   0.005          .0002 (.0003)          0.485   0.007
                               Estradiol, ng/dL                    --.00003 (.0011)                             0.982                          0              .0084 (.0063)                              0.189                        0.027            --.0013 (.0088)          0.88      0           --.0008 (.0022)         0.73    0.002
                     Follicle--stimulating hormone, mIU/mL         **.0260 (.0086)**         **0.004** [\*](#nt121){ref-type="table-fn"}   **0.125**        **.1726 (.0471)**         **0.001** [\*](#nt121){ref-type="table-fn"}   **0.175**           .0475 (.0711)           0.506   0.048         --.0043 (.0183)         0.816   0.001
                           Free Testosterone, pg/mL          --3.77×10^--5^ (6.88×10^--5^)                      0.586                        0.005     --8.8×10^--5^ (38.8×10^--5^)                      0.82                         0.001     --26.1×10^--5^ (53.3×10^--5^)   0.626   0.004   11.2×10^--5^ (13.6×10^--5^)   0.413   0.01
                              Progesterone, ng/mL                    .0003 (.0001)                              0.014                        0.091          **.0018 (.0006)**         **0.002** [\*](#nt121){ref-type="table-fn"}   **0.137**          --.0004 (.0009)          0.676   0.003         --.0001 (.0002)         0.698   0.002
                           Total testosterone, ng/mL               --.00002 (.00007)                            0.827                        0.001          --.00025 (.00040)                            0.535                        0.006           --.00036 (.00055)         0.512   0.007         .00014 (.00014)         0.331   0.015
                                 Tanner stage                                                                                                0.028                                                                                    0.017                                             0.039                                         0.023
                                    Stage 1                            Reference                                                                                Reference                                                                                 Reference                                      Reference                   
                                    Stage 2                      0.997 (0.992, 1.002)                           0.205                                      1.005 (0.989, 1.022)                          0.545                                      1.009 (0.986, 1.034)        0.436              1.002 (0.996, 1.008)       0.517  
                                    Stage 3                      0.994 (0.979, 1.009)                           0.423                                      0.980 (0.912, 1.053)                          0.586                                      0.927 (0.789, 1.089)        0.354              0.987 (0.944, 1.032)       0.564  

Data are presented as β (SE) and R^2^ for linear regression analysis or OR (95%.CI) and Nagelkerke R^2^ for binary logistical regression analysis.

\* *P*\<0.00625 (0.05/8) indicates a significant correlation.

*Abbreviations:* MnBP, mono-n-butyl phthalate; MBzP, mono-benzyl phthalate; MMP, monomethyl phthalate; MEP, mono-ethyl phthalate.

No correlations were shown between urinary phthalate metabolite levels of boys aged eight years with physical characteristics and reproductive development. Lastly, urinary phthalate metabolite levels of eight-year-old children did not correlate with either their physical characteristics or reproductive development ([Table S5](#pone.0102788.s005){ref-type="supplementary-material"}).

Discussion {#s4}
==========

Epidemiological studies have indicated that phthalates may affect reproductive outcomes in children; however, the health effects of specific phthalates in children, in particular DEHP and its metabolites, are unknown [@pone.0102788-Lin1], [@pone.0102788-Jurewicz1]. In the present study, we examined birth outcomes, reproductive hormone levels, and markers of reproductive development of eight-year-old male and female children by following *in utero* and environmental exposure to phthalates. No significant differences were found in *in utero* phthalate exposure between boys and girls, indicating that both boys and girls in this study were exposed to similar levels of phthalate *in utero*.

Phthalates have been previously implicated in affecting fetal development, and in turn, birth outcomes. In a cohort of 404 infants, Wolff *et al*. [@pone.0102788-Wolff1] demonstrated that LMW phthalate metabolites, but not DEHP or HMW phthalate metabolites, were positively associated with gestational age and head circumference after adjusting for multiple factors, including creatinine levels. However, no associations were found between *in utero* phthalate levels and birth weights or birth lengths of newborns. In the present study, with the exception of one circumstance, *in utero* exposure to phthalates did not correlate with birth outcomes. Specifically, maternal urinary MMP levels were found to correlate negatively with birth weight in boys.

Phthalate metabolites have short biological half-lives and are rapidly excreted via urine [@pone.0102788-KasperSonnenberg1]. This is supported by our finding that maternal phthalate levels did not correlate with those of their eight-year-old children. Therefore, we have originally comsidered that maternal/prenatal phthalate exposure and environmental phthalate exposure of 8-year-old children can be treated as two different entities that can be investigated separately. However, previous investigations have shown that prenatal phthalate exposure is associated with childhood behavior at ages 4--9 years [@pone.0102788-Engel1], neurobehavioral development at ages 6--10 years [@pone.0102788-Kobrosly1], male-typical play (masculine play) behavior in boys at ages 3.6--6.4 years [@pone.0102788-Swan2] and childhood eczema at age 2 years [@pone.0102788-Just1]. Therefore, as in the present study, it is also reasonable to hypothesize that prenatal phthalate exposure (maternal exposure) may affect sex steroid hormone levels and reproductive development of 8-year-old children. However, the outcomes of our study did not support the original hypothesis that maternal urinary levels of phthalate metabolites did not correlate with the physical characteristics and reproductive development of eight-year-old children ([Table S4](#pone.0102788.s004){ref-type="supplementary-material"}), which emphasizes the need for additional study.

Phthalates have been suspected to have anti-androgenic and estrogenic effects, which may alter the reproductive development of children [@pone.0102788-Moore1], [@pone.0102788-Harris1]. In fact, some phthalates have been shown to alter or mimic E2 *in vivo* and *in vitro* [@pone.0102788-Harris1]. In terms of environmental exposure to phthalates, as determined by the urinary phthalate metabolite levels of eight-year-old children, certain phthalate metabolites were indeed found to affect their physical characteristics and reproductive hormone levels. Regarding the reproductive hormone of the entire cohort, only MEHP correlated significantly with serum progesterone levels and MnBP correlated significantly with serum FSH levels. Urinary phthalate metabolite levels did not correlate with the physical characteristics and reproductive hormone levels of eight-year-old boys. Conversely, in girls, MEHP and MBzP were found to correlate positively with serum progesterone levels, and MnBP and MBzP correlated positively with serum FSH levels. Indeed, we found that for every 1 µg/L increase in urinary MBzP levels of girls aged eight years, there was an increase in serum FSH levels of 0.1726 mIU/mL (β = 0.1726, SE = 0.0471; *P* = 0.001). While exposure to some phthalates was associated with alterations in reproductive hormone levels in girls, none of the phthalates studied affected female reproductive development. These findings corroborate the results of another study, which demonstrated that phthalate exposure is not associated with precocious puberty in female children aged roughly seven years [@pone.0102788-Lomenick1].

This study has a few limitations that need to be addressed. First, in addition to using a single urine specimen to determine maternal urinary phthalate levels during the third trimester of pregnancy, we did not measure phthalate levels during early pregnancy (i.e., the first trimester), which is when sex determination and differentiation of the fetus occurs. However, Braun *et al*. (2012) had previously determined that, with the exception of BPA and MBzP, the variability of most urinary phthalate metabolites was similar before and during pregnancy, suggesting that maternal urinary phthalate levels may be measured at any stage of pregnancy to determine *in utero* exposure to phthalates [@pone.0102788-Braun1]. Second, given that we studied pre-pubertal children, it may be too early to determine the effects of phthalate exposure on gonadal development in these children by evaluating ovary follicles, endometrial development and uterus length. However, precocious puberty is defined as the development of pubertal changes at an age younger than the accepted lower limits for age at onset of puberty, namely, before age 8 years in girls and 9 years in boys [@pone.0102788-Berberolu1]. Since we aimed to investigate the association between environmental phthalate exposure and abnormal reproductive development, we did not want to miss the disease onset time of CPP and thus started to follow the subjects at 8 to 9 years. Third, it was determined that urinary phthalate metabolite levels have an effect on certain sex hormone levels (i.e., FSH and progesterone in girls). For boys, sertoli cell markers (AMH and inhibin B) in serum are reliable markers for evaluation of basal testicular function in childhood [@pone.0102788-Rey1], but we did not measure the serum levels of AMH and inhibin B in this research project. Of note, we have been continuously following this cohort of children since birth and they are now 12 years of age. Accordingly, we will investigate the effects of urinary phthalate metabolite levels on sexual development and sex hormone levels of 12-year-old children, including gonadal development of both boys and girls, and will measure the major markers of sexual maturation, including AMH and inhibin B.

Conclusion {#s5}
==========

*In utero* phthalate exposure did not significantly alter birth outcomes, growth, or reproductive function and development in pre-pubertal children. Furthermore, environmental exposure to certain phthalate metabolites (i.e., MEHP, MnBP, and MBzP) appears to affect reproductive hormone levels in pre-pubertal girls. Our results suggest that future studies focusing on the environmental health effects of phthalates and their metabolites are warranted.

Supporting Information {#s6}
======================

###### 

**Birth outcomes, including birth weights, birth lengths, and head circumferences, of newborns at different gestational ages.**

(DOC)

###### 

Click here for additional data file.

###### 

**Z- scores of birth outcomes of newborns at different gestational ages.**

(DOC)

###### 

Click here for additional data file.

###### 

**Correlation analysis of maternal urinary levels of phthalate metabolites with birth outcome and the phthalate metabolites levels of eight-year-old children.**

(DOC)

###### 

Click here for additional data file.

###### 

**Correlation analysis of maternal urinary levels of phthalate metabolites with physical characteristics and reproductive development of children at 8 years of age.**

(DOC)

###### 

Click here for additional data file.

###### 

**Correlation analysis of the urinary phthalate metabolite levels of eight-year-old children with their physical characteristics and reproductive development.** Raw data (Sheet 1) and code book (Sheet 2) in an Excel file "Original data.xls".

(DOC)

###### 

Click here for additional data file.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: SLW. Performed the experiments: PCL. Analyzed the data: HYC. Contributed reagents/materials/analysis tools: PHS JYC CYL THY. Wrote the paper: PHS JYC. Specimen collections, tissue arrangement and preparations: HYC.
